Core Operational Strategy: The "Australian Advantage"

A central component of Avance Clinical's value proposition is its ability to help international clients navigate the Australian clinical trial landscape. Key benefits of this model include: * Rapid Start-Up: In Australia, clinical trials can often reach the Site Initiation Visit (SIV) and study start-up phase within 5 to 6 weeks. * No IND Requirement: Phase I clinical trials in Australia do not require an Investigational New Drug (IND) application with the FDA, significantly reducing the initial regulatory burden and administrative delay. * R&D Tax Incentive: Eligible companies can receive a cash rebate of up to 43.5% on their clinical trial spend in Australia, making it one of the most cost-effective destinations for high-quality drug development.

Strategic Service Models (Products)

Avance Clinical offers specialized "pathway" products that manage the continuity of a drug's development lifecycle:

1. ClinicReady (Preclinical Support)

The ClinicReady team consists of PhD-qualified scientific and regulatory affairs specialists who provide the foundational work required before a drug enters human trials. Services include: * Scientific Gap Analysis: Reviewing preclinical data to identify potential hurdles for clinical entry. * Regulatory Roadmapping: Developing a strategy for global agency engagement. * Dossier Preparation: Drafting Investigator?s Brochures (IB) and Investigational Medicinal Product Dossiers (IMPD).

2. GlobalReady (Phase I to Phase III Transition)

GlobalReady is a proprietary model designed to support biotechs as they transition from early-phase studies in Australia and New Zealand to larger, multi-regional Phase II and III trials. This model ensures that the same project management and data standards are maintained throughout the process, preventing the "knowledge loss" that often occurs when switching CROs between phases.

3. Centers of Excellence

Avance Clinical has established dedicated Centers of Excellence to provide specialized expertise in high-complexity therapeutic areas: * Oncology Center of Excellence: Following the acquisition of the US-based CRO LumaBridge, this center provides deep expertise in solid tumors and hematologic malignancies, helping sponsors manage complex dose-escalation and expansion cohorts. * CNS (Central Nervous System) Center of Excellence: Specializing in trials for Alzheimer?s, Parkinson?s, and rare neurological disorders.

Clinical Services and Capabilities

Avance Clinical provides a "one-stop-shop" for clinical trial execution, encompassing several functional departments:

Clinical Operations and Project Management

The company utilizes an "A-Team" approach, where clients are assigned dedicated project managers who oversee site identification, feasibility assessments, and vendor management. Their clinical trial monitors (CRAs) ensure rigorous adherence to Good Clinical Practice (GCP) through both on-site and remote monitoring.

Biometrics and Data Management

Avance Clinical has a world-class reputation for data integrity. Their biometrics services include: * EDC System Setup: Designing electronic data capture systems using industry-standard platforms. * Biostatistics: Providing specialized trial design, sample size calculations, and statistical analysis plans (SAP). * Pharmacokinetic (PK) Analysis: High-level analysis of drug absorption, distribution, metabolism, and excretion.

Scientific and Medical Writing

The medical writing team, largely composed of doctorate-trained professionals with decades of experience, produces all necessary trial documentation, including: * Clinical Study Protocols * Clinical Study Reports (CSR) * Peer-reviewed journal manuscripts

Patient Recruitment and Site Partnerships

Avance Clinical maintains a "Global Site Partnership Network," giving sponsors access to more than 2,000 highly qualified clinical sites. Their patient-centric recruitment strategies involve engaging with advocacy groups and utilizing digital tools to ensure rapid enrollment, particularly in rare disease and orphan drug trials where patient populations are limited.

Quality Assurance (QA) and Regulatory Affairs

The in-house QA department conducts routine audits of trial sites and internal processes to guarantee that the data is "submission-ready." The Global Scientific and Regulatory Affairs team acts as a bridge to agencies like the FDA and EMA, helping sponsors navigate Orphan Drug Designations, Fast Track statuses, and meeting preparations.

Geographic Presence

While headquartered in Adelaide, South Australia, Avance Clinical has expanded its global reach with offices and teams in: * North America: Operations based in North Carolina, USA. * New Zealand: Supporting early-phase trials across various regional centers. * Asia: Strategic operations in Seoul (South Korea), Taiwan, and Bengaluru (India). * Europe: Integrated services to support multi-regional expansion for later-phase studies.